“Investors in biotech stocks need to find targets with positive catalysts on the near- to mid-term horizon, including promising drug candidates and/or novel approaches to unmet medical needs.”
Companies involved in life sciences (including for COVID-19), home healthcare and cell therapies are among the six new biotech stocks to watch.
A rectangle pattern has formed for the biotech stock featured in today’s article, and the author advises that “When this pattern is broken, a breakout or breakdown is expected.”
“If you only have enough time to keep up with a handful of biotech catalysts that are on the way soon, these three are well worth your attention.”
A clinical-stage company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases is among the three new biotech stocks to watch.
Among the three top biotech stocks to buy right now, as identified by the author of today’s article, is a company that he argues “deserves… Read More »“The Overall Best Biotech Around” – And 2 Other Top Biotech Stock Picks
Is the current downturn a good buying opportunity for biotech stocks? And, if so, which biotech stocks are the most promising picks for aggressive investors?
Two penny stocks that boast “Strong Buy” consensus ratings from the analyst community and massive upside potential.
A clinical-stage biotech company focused on developing tumor-specific immunotherapies to fight multiple cancer types and which is also developing a COVID-19 vaccine that could aid in the battle against variant strains of the virus.
Covid-19 vaccines aren’t the only ones you should be paying attention to” – and they highlight seven “second-tier” biotechs with catalysts beyond COVID-19 vaccines that may be worth considering.